Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in te...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia Brasileira de Neurologia (ABNEURO)
2020-01-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028&tlng=en |
| _version_ | 1798020523339284480 |
|---|---|
| author | Miriam da Costa OLIVEIRA Liselotte Menke BAREA Andreia Peres Klein HORN Bárbara Roberta ONGARATTI José Otávio Dworzeki SOARES Bruna ARAUJO Tainá Mafalda dos SANTOS Carolina Leães RECH Júlia Fernanda Semmelmann PEREIRA-LIMA |
| author_facet | Miriam da Costa OLIVEIRA Liselotte Menke BAREA Andreia Peres Klein HORN Bárbara Roberta ONGARATTI José Otávio Dworzeki SOARES Bruna ARAUJO Tainá Mafalda dos SANTOS Carolina Leães RECH Júlia Fernanda Semmelmann PEREIRA-LIMA |
| author_sort | Miriam da Costa OLIVEIRA |
| collection | DOAJ |
| description | Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain. |
| first_indexed | 2024-04-11T16:58:59Z |
| format | Article |
| id | doaj.art-5a33feebf8ec4139b2403f5112142fd0 |
| institution | Directory Open Access Journal |
| issn | 1678-4227 |
| language | English |
| last_indexed | 2024-04-11T16:58:59Z |
| publishDate | 2020-01-01 |
| publisher | Academia Brasileira de Neurologia (ABNEURO) |
| record_format | Article |
| series | Arquivos de Neuro-Psiquiatria |
| spelling | doaj.art-5a33feebf8ec4139b2403f5112142fd02022-12-22T04:13:12ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-42272020-01-01781283310.1590/0004-282x20190143Resolution of headache after reduction of prolactin levels in hyperprolactinemic patientsMiriam da Costa OLIVEIRAhttps://orcid.org/0000-0002-7091-513XLiselotte Menke BAREAhttps://orcid.org/0000-0002-9531-9115Andreia Peres Klein HORNhttps://orcid.org/0000-0003-1621-3468Bárbara Roberta ONGARATTIhttps://orcid.org/0000-0002-7953-2952José Otávio Dworzeki SOAREShttps://orcid.org/0000-0001-6204-0049Bruna ARAUJOhttps://orcid.org/0000-0002-9443-9924Tainá Mafalda dos SANTOShttps://orcid.org/0000-0002-2243-6919Carolina Leães RECHhttps://orcid.org/0000-0003-4603-6968Júlia Fernanda Semmelmann PEREIRA-LIMAhttps://orcid.org/0000-0001-8207-9119Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028&tlng=enheadachepituitary adenomasprolactinhyperprolactinemiadopaminergic agonist |
| spellingShingle | Miriam da Costa OLIVEIRA Liselotte Menke BAREA Andreia Peres Klein HORN Bárbara Roberta ONGARATTI José Otávio Dworzeki SOARES Bruna ARAUJO Tainá Mafalda dos SANTOS Carolina Leães RECH Júlia Fernanda Semmelmann PEREIRA-LIMA Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients Arquivos de Neuro-Psiquiatria headache pituitary adenomas prolactin hyperprolactinemia dopaminergic agonist |
| title | Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| title_full | Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| title_fullStr | Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| title_full_unstemmed | Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| title_short | Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| title_sort | resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
| topic | headache pituitary adenomas prolactin hyperprolactinemia dopaminergic agonist |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028&tlng=en |
| work_keys_str_mv | AT miriamdacostaoliveira resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT liselottemenkebarea resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT andreiapereskleinhorn resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT barbararobertaongaratti resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT joseotaviodworzekisoares resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT brunaaraujo resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT tainamafaldadossantos resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT carolinaleaesrech resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients AT juliafernandasemmelmannpereiralima resolutionofheadacheafterreductionofprolactinlevelsinhyperprolactinemicpatients |